−5.12MXN
−4.35 BMXN
2.12 BMXN
About IMMUNOGEN INC
Sector
Industry
Headquarters
Waltham
Website
Employees (FY)
277
Founded
1981
ISIN
US45253H1014
FIGI
BBG00PGGZ3F0
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMGN is 268.50 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange IMMUNOGEN INC stocks are traded under the ticker IMGN.
IMMUNOGEN INC is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
IMGN stock is 0% volatile and has beta coefficient of −0.44. Check out the list of the most volatile stocks — is IMMUNOGEN INC there?
One year price forecast for IMMUNOGEN INC has a max estimate of 521.43 MXN and a min estimate of 521.43 MXN.
IMGN earnings for the last quarter are 1.74 MXN whereas the estimation was 0.77 MXN which accounts for 125.46% surprise. Estimated earnings for the next quarter are 2.20 MXN. See more details about IMMUNOGEN INC earnings.
IMMUNOGEN INC revenue for the last quarter amounts to 1.98 B MXN despite the estimated figure of 1.81 B MXN. In the next quarter revenue is expected to reach 2.20 B MXN.
Yes, you can track IMMUNOGEN INC financials in yearly and quarterly reports right on TradingView.
IMGN net income for the last quarter is 535.96 M MXN, while the quarter before that showed −72.81 M MXN of net income which accounts for 836.06% change. Track more IMMUNOGEN INC financial stats to get the full picture.
No, IMGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNOGEN INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 277.00 employees. See our rating of the largest employees — is IMMUNOGEN INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUNOGEN INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUNOGEN INC stock shows the buy signal. See more of IMMUNOGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IMMUNOGEN INC future price: according to them, IMGN price has a max estimate of 521.43 MXN and a min estimate of 521.43 MXN. Read a more detailed IMMUNOGEN INC forecast: see what analysts think of IMMUNOGEN INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMUNOGEN INC EBITDA is −1.37 B MXN, and current EBITDA margin is −201.42%. See more stats in IMMUNOGEN INC financial statements.